关注
Debra Dorotea
Debra Dorotea
Department of Laboratory Medicine, Karolinska Institutet
在 ki.se 的电子邮件经过验证
标题
引用次数
引用次数
年份
Recent insights into SREBP as a direct mediator of kidney fibrosis via lipid-independent pathways
D Dorotea, D Koya, H Ha
Frontiers in Pharmacology 11, 265, 2020
692020
Fyn kinase: A potential therapeutic target in acute kidney injury
MJ Uddin, D Dorotea, ES Pak, H Ha
Biomolecules & therapeutics 28 (3), 213, 2020
332020
TM5441, a plasminogen activator inhibitor-1 inhibitor, protects against high fat diet-induced non-alcoholic fatty liver disease
SM Lee, D Dorotea, I Jung, T Nakabayashi, T Miyata, H Ha
Oncotarget 8 (52), 89746, 2017
252017
Orally active, species-independent novel A3 adenosine receptor antagonist protects against kidney injury in db/db mice
D Dorotea, A Cho, G Lee, G Kwon, J Lee, PK Sahu, LS Jeong, DR Cha, ...
Experimental & Molecular Medicine 50 (4), 1-14, 2018
202018
A pan-NADPH oxidase inhibitor ameliorates kidney injury in type 1 diabetic rats
D Dorotea, G Kwon, JH Lee, E Saunders, YS Bae, SH Moon, SJ Lee, ...
Pharmacology 102 (3-4), 180-189, 2018
182018
Renoprotective potentials of small molecule natural products targeting mitochondrial dysfunction
MA Rahman, S Akter, D Dorotea, A Mazumder, MN Uddin, MA Hannan, ...
Frontiers in Pharmacology 13, 925993, 2022
172022
Pan-Src kinase inhibitor treatment attenuates diabetic kidney injury via inhibition of Fyn kinase-mediated endoplasmic reticulum stress
D Dorotea, S Jiang, ES Pak, JB Son, HG Choi, SM Ahn, H Ha
Experimental & Molecular Medicine 54 (8), 1086-1097, 2022
162022
Activation of β2 adrenergic receptor signaling modulates inflammation: a target limiting the progression of kidney diseases
D Dorotea, H Ha
Archives of Pharmacal Research 44 (1), 49-62, 2021
162021
Impaired Peroxisomal Fitness in Obese Mice, a Vicious Cycle Exacerbating Adipocyte Dysfunction via Oxidative Stress
L Piao, D Dorotea, S Jiang, EH Koh, GT Oh, H Ha
Antioxidants & Redox Signaling 31 (18), 1339-1351, 2019
152019
Dojuksan ameliorates tubulointerstitial fibrosis through irisin-mediated muscle-kidney crosstalk
S Jiang, DS Oh, D Dorotea, E Son, DS Kim, H Ha
Phytomedicine 80, 153393, 2021
132021
Peroxisomal fitness: a potential protective mechanism of fenofibrate against high fat diet-induced non-alcoholic fatty liver disease in mice
S Jiang, MJ Uddin, X Yu, L Piao, D Dorotea, GT Oh, H Ha
Diabetes & Metabolism Journal 46 (6), 829-842, 2022
92022
KF-1607, a novel pan src kinase inhibitor, attenuates obstruction-induced tubulointerstitial fibrosis in mice
D Dorotea, S Lee, SJ Lee, G Lee, JB Son, HG Choi, SM Ahn, H Ha
Biomolecules & Therapeutics 29 (1), 41, 2021
92021
Knockdown of PEX16 induces autophagic degradation of peroxisomes
X Wei, Y Maharjan, D Dorotea, RK Dutta, D Kim, H Kim, Y Mu, C Park, ...
International Journal of Molecular Sciences 22 (15), 7989, 2021
52021
P0719 SRC kinases aggravate diabetic kidney injury through activation of endoplasmic reticulum stress
D Dorotea, H Ha
Nephrology Dialysis Transplantation 35 (Supplement_3), gfaa142. P0719, 2020
12020
SRC KINASES AGGRAVATE DIABETIC KIDNEY INJURY THROUGH ACTIVATION OF ENDOPLASMIC RETICULUM STRESS
D Dorotea, H Ha
NEPHROLOGY DIALYSIS TRANSPLANTATION 35, 1043-1043, 2020
2020
Src kinases inhibition ameliorates diabetic kidney injury in association with decreased endoplasmic reticulum stress
D Dorotea
International Congress of Diabetes and Metabolism 2018, 192-192, 2018
2018
APX-115, a pan-NADPH oxidase (Nox) inhibitor, attenuates kidney injury in streptozotocin-induced diabetic rats
D Dorotea, G Kwon
International Congress of Diabetes and Metabolism 2017, 138-138, 2017
2017
系统目前无法执行此操作,请稍后再试。
文章 1–17